Authors:
MIDDLETON MR
LUNN JM
MORRIS C
RUSTIN G
WEDGE SR
BRAMPTON MH
LIND MJ
LEE SM
NEWELL DR
BLEEHEN NM
NEWLANDS ES
CALVERT AH
MARGISON GP
THATCHER N
Citation: Mr. Middleton et al., O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN PRETREATMENT TUMOR-BIOPSIES AS A PREDICTOR OF RESPONSE TO TEMOZOLOMIDE IN MELANOMA, British Journal of Cancer, 78(9), 1998, pp. 1199-1202
Authors:
BOWER M
NEWLANDS ES
BLEEHEN NM
BRADA M
BEGENT RJH
CALVERT H
COLQUHOUN I
LEWIS P
BRAMPTON MH
Citation: M. Bower et al., MULTICENTER CRC PHASE-II TRIAL OF TEMOZOLOMIDE IN RECURRENT OR PROGRESSIVE HIGH-GRADE GLIOMA, Cancer chemotherapy and pharmacology, 40(6), 1997, pp. 484-488
Authors:
NEWLANDS ES
OREILLY SM
GLASER MG
BOWER M
EVANS H
BROCK C
BRAMPTON MH
COLQUHOUN I
LEWIS P
RICEEDWARDS JM
ILLINGWORTH RD
RICHARDS PG
Citation: Es. Newlands et al., THE CHARING-CROSS-HOSPITAL EXPERIENCE WITH TEMOZOLOMIDE IN PATIENTS WITH GLIOMAS, European journal of cancer, 32A(13), 1996, pp. 2236-2241
Authors:
BOOTE DJ
DENNIS IF
TWENTYMAN PR
OSBORNE RJ
LABURTE C
HENSEL S
SMYTH JF
BRAMPTON MH
BLEEHEN NM
Citation: Dj. Boote et al., PHASE-I STUDY OF ETOPOSIDE WITH SDZ PSC 833 AS A MODULATOR OF MULTIDRUG-RESISTANCE IN PATIENTS WITH CANCER, Journal of clinical oncology, 14(2), 1996, pp. 610-618
Authors:
KERR DJ
RUSTIN GJ
KAYE SB
SELBY P
BLEEHEN NM
HARPER P
BRAMPTON MH
Citation: Dj. Kerr et al., PHASE-II TRIALS OF RHIZOXIN IN ADVANCED OVARIAN, COLORECTAL AND RENAL-CANCER, British Journal of Cancer, 72(5), 1995, pp. 1267-1269